Elizabeth S Duke

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 19

Top Topics

Drug Administration

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
FDA Approval Summary: Eflornithine for High-Risk Neuroblastoma Following Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jason R Fangusaro, Robert A Avery, Michael J Fisher, Roger J Packer, Karin S Walsh, Antoinette Y N Schouten-van Meeteren, Dominik Karres, Diana Bradford, Vishal Bhatnagar, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Jason R Fangusaro, Robert A Avery, Michael J Fisher, Roger J Packer, Karin S Walsh, Antoinette Y N Schouten-van Meeteren, Dominik Karres, Diana Bradford, Vishal Bhatnagar, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Jason R Fangusaro, Robert A Avery, Michael J Fisher, Roger J Packer, Karin S Walsh, Antoinette Y N Schouten-van Meeteren, Dominik Karres, Diana Bradford, Vishal Bhatnagar, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Jason R Fangusaro, Robert A Avery, Michael J Fisher, Roger J Packer, Karin S Walsh, Antoinette Y N Schouten-van Meeteren, Dominik Karres, Diana Bradford, Vishal Bhatnagar, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
FDA Approval Summary: Eflornithine for High-Risk Neuroblastoma Following Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jason R Fangusaro, Robert A Avery, Michael J Fisher, Roger J Packer, Karin S Walsh, Antoinette Y N Schouten-van Meeteren, Dominik Karres, Diana Bradford, Vishal Bhatnagar, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Jason R Fangusaro, Robert A Avery, Michael J Fisher, Roger J Packer, Karin S Walsh, Antoinette Y N Schouten-van Meeteren, Dominik Karres, Diana Bradford, Vishal Bhatnagar, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Elizabeth S Duke, Diana Bradford, Arup K Sinha, Pallavi S Mishra-Kalyani, Catherine C Lerro, Donna R Rivera, Emily Wearne, Claudia P Miller, John Leighton, Hairat Sabit, Hong Zhao, Ashley Lane, Barbara Scepura, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Martha Donoghue, Nicole Drezner
FDA Approval Summary: Eflornithine for High-Risk Neuroblastoma Following Prior Multiagent, Multimodality Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Elizabeth S Duke, Diana Bradford, Michelle Marcovitz, Anup K Amatya, Pallavi S Mishra-Kalyani, Emily Nguyen, Lauren S L Price, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jeffrey Kraft, Sarah E Dorff, Barbara Scepura, Maritsa Stephenson, Idara Ojofeitimi, Abhilasha Nair, Yu Han, Zivana Tezak, Steven J Lemery, Richard Pazdur, Erin Larkins, Harpreet Singh
FDA Approval Summary: Selpercatinib for the treatment of advanced RET fusion-positive solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Elizabeth S Duke, Diana Bradford, Michelle Marcovitz, Anup K Amatya, Pallavi S Mishra-Kalyani, Emily Nguyen, Lauren S L Price, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jeffrey Kraft, Sarah E Dorff, Barbara Scepura, Maritsa Stephenson, Idara Ojofeitimi, Abhilasha Nair, Yu Han, Zivana Tezak, Steven J Lemery, Richard Pazdur, Erin Larkins, Harpreet Singh
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Elizabeth S Duke, Michael J Fusco, Patrick DeMoss, Asma Dilawari, Gulsum E Pamuk, Jessica Boehmer, Bronwyn D Mixter, Kirsten B Goldberg, Paul G Kluetz, Richard Pazdur
Highlights of FDA Oncology Approvals in 2022: Tissue-Agnostic Indications, Dosage Optimization, and Diversity in Drug Development. Cancer discovery 12 (12) (2022)
Elizabeth S Duke, Liza Stapleford, Nicole Drezner, Anup K Amatya, Pallavi S Mishra-Kalyani, Yuan Li Shen, Kimberly Maxfield, Jeanne F Zirkelbach, Youwei Bi, Jiang Liu, Xinyuan Zhang, Hezhen Wang, Yuching Yang, Nan Zheng, Kelie Reece, Emily Wearne, Jacqueline J Glen, Idara Ojofeitimi, Barbara Scepura, Abhilasha Nair, Rama Kamesh Bikkavilli, Soma Ghosh, Reena Philip, Richard Pazdur, Julia A Beaver, Harpreet Singh, Martha Donoghue
FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Elizabeth S Duke, Amy K Barone, Somak Chatterjee, Pallavi S Mishra-Kalyani, Yuan-Li Shen, Emasenyie Isikwei, Hong Zhao, Youwei Bi, Jiang Liu, Nam Atiqur Rahman, Emily Wearne, John K Leighton, Maritsa Stephenson, Idara Ojofeitimi, Barbara Scepura, Abhilasha Nair, Richard Pazdur, Julia A Beaver, Harpreet Singh
FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)